DPP4 and type 2 diabetes mellitus: 147 Seong Seong J.M. J.M. Choi Choi N.K. N.K. Shin Shin J.Y. J.Y. Chang Chang Y. Y. Kim Kim Y.J. Y.J. Lee Lee J. J. Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: A population-based cohort study Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: A population-based cohort study PLoS One.